Semaxinib: all 22 studies that test it

Page 1 of 1. Open to participants first (0), then studies with results posted, then the rest; newest registration first within each.

• SU5416 Plus Hormone Therapy and Radiation Therapy in Treating Patients With Prostate CancerCompletedNCT00026377Phase 1
• SU5416 in Treating Patients With Persistent or Recurrent Cervical CancerCompletedNCT00026260Phase 2
• Radiation Therapy With or Without SU5416 in Treating Patients With Soft Tissue SarcomaCompletedNCT00023725Phase 1/2
• SU5416 in Treating Patients With Metastatic Kidney Cancer That Has Not Responded to Previous TreatmentTerminatedNCT00009919Phase 2
• SU5416 in Treating Patients With Advanced or Recurrent Cancer of the Head and NeckCompletedNCT00006361Phase 2
• SU5416 in Treating Children With Recurrent or Progressive Brain TumorsTerminatedNCT00006247Phase 1
• SU5416 and Carboplatin to Treat Ovarian CancerCompletedNCT00006155Phase 1
• SU5416 in Treating Patients With Malignant MesotheliomaCompletedNCT00006014Phase 2
• SU5416 in Treating Patients With Refractory or Relapsed Multiple MyelomaCompletedNCT00006013Phase 2
• SU5416 in Treating Patients With Metastatic Melanoma That Has Been Previously TreatedTerminatedNCT00006003Phase 2
• SU5416 in Treating Patients With Metastatic or Locally Recurrent Colorectal CancerTerminatedNCT00006001Phase 2
• Liposomal Daunorubicin and SU5416 in Treating Patients With Hematologic Cancer That Has Not Responded to Initial TherapyCompletedNCT00005942Phase 1/2
• SU5416 in Patients With AIDS-Related Kaposi's Sarcoma Who Have Not Responded to TreatmentCompletedNCT00005931Phase 2
• SU5416 in Treating Patients With Advanced, Metastatic, or Recurrent Soft Tissue SarcomasCompletedNCT00005862Phase 2
• SU5416 and Doxorubicin in Treating Patients With Stage IIIB or Stage IV Inflammatory Breast CancerCompletedNCT00005822Phase 1
• SU5416 and Irinotecan in Treating Patients With Advanced Colorectal CancerCompletedNCT00005818Phase 1/2
• SU5416 and Paclitaxel in Treating Patients With Recurrent, Locally Advanced or Metastatic Cancer of the Head and NeckCompletedNCT00005647Phase 1
• SU5416 in Treating Patients With Advanced Solid TumorsCompletedNCT00005642Phase 1
• SU5416 in Treating Patients With AIDS-Related Kaposi's SarcomaCompletedNCT00005042Phase 2
• SU5416 in Treating Patients With Recurrent Astrocytoma or Mixed Glioma That Has Not Responded to Radiation TherapyCompletedNCT00004868Phase 1/2
• SU5416 in Treating Patients With AIDS-Related Kaposi's SarcomaCompletedNCT00003720Phase 1
• Safety and Effectiveness of Giving SU5416 to HIV-Infected Patients With AIDS-Related Kaposi's SarcomaCompletedNCT00002226Not applicable

← Semaxinib overview